Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Forecast: What Value Will The Market Reach By 2030?
The market size for respiratory devices and equipment (therapeutic and diagnostic) has experienced rapid growth in recent years. This market is set to expand from $13.62 billion in 2025 to $15.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be ascribed to the increasing prevalence of chronic respiratory disorders, the expansion of hospital respiratory care units, a rising demand for long-term oxygen therapy, improvements in ventilator technology, and the growing use of non-invasive respiratory support.
The respiratory devices and equipment (therapeutic and diagnostic) market size is projected for substantial growth in the upcoming years, with expectations to reach $27.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.3%. This expansion over the forecast period is propelled by factors such as the increasing demand for homecare respiratory solutions, the growing adoption of connected respiratory devices, the broadening of tele-respiratory care services, increased investments in advanced ventilatory technologies, and a sustained focus on patient-centric respiratory management. Significant trends within this timeframe include the increasing uptake of integrated diagnostic and therapeutic respiratory systems, the rising deployment of home-based respiratory care devices, the growing utilization of smart ventilation and oxygen therapy equipment, the expansion of continuous respiratory monitoring solutions, and an enhanced emphasis on chronic respiratory disease management.
Get A Free Sample Report With In-Depth Market Insights:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Growth Backed By Core Demand Fundamentals
The rising occurrence of diverse respiratory ailments is anticipated to drive the expansion of the respiratory devices and equipment (therapeutic and diagnostic) market in the future. These conditions are characterized by impacts on the lungs and airways, hindering typical breathing and oxygen transfer, often caused by inflammation, infections, blockages, or lasting structural harm. The heightened incidence of such diseases stems from an escalating worldwide burden of ailments that gradually diminish lung capacity and heighten populations’ susceptibility to enduring respiratory issues. To stabilize patient health, respiratory devices and equipment aid in managing these illnesses by enhancing airflow, boosting oxygen supply, and facilitating more efficient oversight of lung performance. For example, data from June 2025 by the World Health Organization, an entity located in Switzerland, indicates that 81.7 million individuals are currently affected by chronic respiratory diseases, with an additional 6.8 million new diagnoses annually. Consequently, the growing frequency of various respiratory conditions acts as a significant catalyst for the respiratory devices and equipment (therapeutic and diagnostic) market.
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Segments: Where Is Growth Concentrated?
The respiratory devices and equipment (therapeutic and diagnostic) market covered in this report is segmented –
1) By Type: Diagnostic devices, Therapeutic devices, Monitoring devices
2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia
3) By End User: Hospitals, Clinics, Homecare settings, Ambulatory service centers
Subsegments:
1) By Diagnostic Devices: Spirometers, Pulse Oximeters, Arterial Blood Gas (ABG) Analyzers, Capnometers, Peak Flow Meters
2) By Therapeutic Devices: Nebulizers, Inhalers (Metered-Dose Inhalers, Dry Powder Inhalers), Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators
3) By Monitoring Devices: Respiratory Rate Monitors, Blood Oxygen Saturation Monitors, Capnography Monitors, Pulmonary Function Monitors
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Growth Trends Reshaping The Competitive Landscape
Leading firms within the respiratory devices and equipment (therapeutic and diagnostic) market are developing novel technological offerings, like the VitaloPFT series, to boost their market profitability. This VitaloPFT Series represents a collection of instruments for assessing pulmonary function. As an illustration, in March 2023, Vitalograph Ltd., a US-based company specializing in respiratory medical devices, introduced the respiratory VitaloPFT series. Designed to deliver high-quality, precise, and reliable respiratory medical equipment and services, this series is purposed for application in secondary care settings. The VitaloPFT Series offers sophisticated respiratory diagnostic solutions for hospitals and other secondary care facilities demanding complex diagnostic capabilities.
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Industry Leaders And Competitive Landscape
Major companies operating in the respiratory devices and equipment (therapeutic and diagnostic) market are Smiths Medical Inc., Philips Healthcare, GE Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Koninklijke Philips N.V., Dragerwerk AG, Medtronic plc, Masimo Corp., CareFusion Corporation, Compumedics Limited, Becton Dickinson and Company, Hamilton Medical, Mindray Medical International Limited, Vyaire Medical Inc., Getinge AB, AirSep Corporation, Breas Medical AB, Hill-Rom Holdings Inc., Inogen, Shenzhen Mindray Bio-Medical Electronics Co., Linde plc, DeVilbiss Healthcare LLC, Nihon Kohden Corporation, Nonin Medical Inc., O2 Concepts LLC, Precision Medical Inc., Pulmodyne Inc., Salter Labs Inc., Sechrist Industries Inc., Teleflex Inc., Ventec Life Systems, VitalAire, Weinmann Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation
View The Full Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Report:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Regional Analysis And Top Geography
Asia-Pacific was the largest region in respiratory devices and equipment (therapeutic and diagnostic) market in 2025. Western Europe was the second-largest region in respiratory devices and equipment (therapeutic and diagnostic) market. The regions covered in the respiratory devices and equipment (therapeutic and diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
